Nea Management Company, LLC Verona Pharma PLC Transaction History
Nea Management Company, LLC
- $1.05 Billion
- Q1 2025
A detailed history of Nea Management Company, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 2,688,565 shares of VRNA stock, worth $201 Million. This represents 16.19% of its overall portfolio holdings.
Number of Shares
2,688,565
Previous 5,584,753
51.86%
Holding current value
$201 Million
Previous $259 Million
34.18%
% of portfolio
16.19%
Previous 18.53%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$491 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$413 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$294 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$259 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$217 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.56B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...